In this episode of our Therapeutic Science and Strategy Podcast, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean’s Professor of Biological Sciences, Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering and Urology, to explore:

  • Historical perspective on personalized approaches to cancer treatment
  • Liquid biopsy as a means to facilitate adaptive treatment regimens tailored to individual cancers
  • Vision of where the field is going and future management paradigms